Tissue-specific genetic variation suggests distinct molecular pathways between body shape phenotypes and colorectal cancer.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
19 Apr 2024
Historique:
medline: 19 4 2024
pubmed: 19 4 2024
entrez: 19 4 2024
Statut: ppublish

Résumé

It remains unknown whether adiposity subtypes are differentially associated with colorectal cancer (CRC). To move beyond single-trait anthropometric indicators, we derived four multi-trait body shape phenotypes reflecting adiposity subtypes from principal components analysis on body mass index, height, weight, waist-to-hip ratio, and waist and hip circumference. A generally obese (PC1) and a tall, centrally obese (PC3) body shape were both positively associated with CRC risk in observational analyses in 329,828 UK Biobank participants (3728 cases). In genome-wide association studies in 460,198 UK Biobank participants, we identified 3414 genetic variants across four body shapes and Mendelian randomization analyses confirmed positive associations of PC1 and PC3 with CRC risk (52,775 cases/45,940 controls from GECCO/CORECT/CCFR). Brain tissue-specific genetic instruments, mapped to PC1 through enrichment analysis, were responsible for the relationship between PC1 and CRC, while the relationship between PC3 and CRC was predominantly driven by adipose tissue-specific genetic instruments. This study suggests distinct putative causal pathways between adiposity subtypes and CRC.

Identifiants

pubmed: 38640244
doi: 10.1126/sciadv.adj1987
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadj1987

Auteurs

Laia Peruchet-Noray (L)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

Anja M Sedlmeier (AM)

Center for Translational Oncology, University Hospital Regensburg, Regensburg, Germany.
Bavarian Cancer Research Center (BZKF), Regensburg, Germany.
Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Niki Dimou (N)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.

Hansjörg Baurecht (H)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Béatrice Fervers (B)

Département Prévention Cancer Environnement, Centre Léon Bérard, Lyon, France.

Emma Fontvieille (E)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.

Julian Konzok (J)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Kostas K Tsilidis (KK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Sofia Christakoudi (S)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Department of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, London, UK.

Anna Jansana (A)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.

Reynalda Cordova (R)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
Department of Nutritional Sciences, University of Vienna, Vienna, Austria.

Patricia Bohmann (P)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Michael J Stein (MJ)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Andrea Weber (A)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Stéphane Bézieau (S)

Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Andrew T Chan (AT)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Iona Cheng (I)

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.

Jane C Figueiredo (JC)

Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Koldo Garcia-Etxebarria (K)

Biodonostia, Gastrointestinal Genetics Group, San Sebastián, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

Victor Moreno (V)

Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.
ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Christina C Newton (CC)

Department of Population Science, American Cancer Society, Atlanta, GA, USA.

Stephanie L Schmit (SL)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Population and Cancer Prevention Program, Case Comprehensive Cancer Center, Cleveland, OH, USA.

Mingyang Song (M)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Departments of Epidemiology and Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.

Cornelia M Ulrich (CM)

Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.

Pietro Ferrari (P)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.

Vivian Viallon (V)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.

Robert Carreras-Torres (R)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), Salt, Girona, Spain.

Marc J Gunter (MJ)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.

Heinz Freisling (H)

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.

Classifications MeSH